SUMMARY The gut hormone response to a breakfast meal was studied in 12 subjects hospitalised for an episode of acute diarrhoea (presumed infective) who were otherwise well and in 13 healthy control subjects. Fasting blood glucose concentrations were low but basal insulin concentrations were raised. Basal concentrations of pancreatic polypeptide and both basal and postprandial responses of motilin, enteroglucagon, and vasoactive intestinal polypeptide (VIP) were also significantly greater than controls. No abnormalities in plasma concentrations of gastrin, gastric inhibitory polypeptide (GIP) or pancreatic glucagon were found. The suggested physiological actions of the raised hormones may be relevant to the pathophysiology of diarrhoea.
The acute, spontaneous onset of diarrhoea in a previously healthy individual is generally considered to be the result of an enteritis which may be caused by ingestion of a bacterial toxin, or by direct viral or bacterial infection.' Often the causative agent is not identified and treatment consists of supportive measures only and complete recovery follows within a short period of time.
Major abnormalities in water and electrolyte transport exist in infectious diarrhoea owing to raised adenylcyclase and cAMP activity, diminished Na+, K+-ATPase activity, loss of epithelial integrity, rapid transit and disorders of intestinal motility.2 The relative importance of these mechanisms probably varies depending on the aetiology.
A number of gut hormones are thought to affect intestinal secretion and motility. The jejunal hormone, motilin, has pronounced effects on gastrointestinal motility,3 affecting the interdigestive migrating complexes.4 Indirect evidence suggests that enteroglucagon is trophic to the mucosa of the small intestine and has the effect of slowing intestinal transit.5
In order to ascertain whether motilin and enteroglucagon or any other gut peptide was altered in acute diarrhoea, we measured the plasma concentrations of these peptides in patients with an acute attack of severe transient diarrhoea.
A test breakfast was given to 12 patients, five women and seven men with acute diarrhoea whose mean age was 37 years (range years). All had been previously in good health and none had a past history of gastrointestinal disease. They had all required admission to hospital for severe diarrhoea (at least eight motions per day) and had been treated on admission with intravenous fluid and electrolyte replacement. In addition, a further four patients had fasting samples taken between admission and discharge (but no test breakfast). Thus in all, 16 subjects were studied on admission and during recovery.
Salmonella agona and saint-paul were isolated from stool specimens in two patients. In one patient's mother, who had also had acute diarrhoea, Salmonella tennessee was isolated but no organism was found in the patient studied. Entamoeba coli were identified in two further patients. No salmonella, shigella or other organisms were cultured in the other 10 patients, nor were ova, cysts, or pathogenic parasites observed on stool microscopy. Barium enema radiology was performed in two patients with Entamoeba coli but was normal in each case. All patients subsequently made complete and lasting recoveries. Blood glucose estimation was carried out using standard glucose oxidase/peroxidase methodology as adapted for the auto-analyser.6 Plasma hormone concentrations were measured by specific radioimmunoassays, which have previously been described in detail, and were carried out by conventional methods with antisera raised to pure human gastrin,7 pancreatic polypeptide,8 and insulin9 to pure porcine gastric inhibitory polypeptide (GIP),10 motilin,1 and vasoactive intestinal polypeptide (VIP).'2 Glucagon was measured using two separate systems, one using a C-terminal reacting antibody specific for pancreatic glucagon13 and a second reacting with the mid to N-terminal sequence of glucagon which also measured gut glucagon immunoreactivity, and which showed complete crossreactivity with porcine glicentin. 14 Enteroglucagon was derived by subtraction of the specific pancreatic glucagon values from those obtained using the N-terminal glucagon assay. The assays were capable of detecting the following plasma changes with 95% confidence: gastrin 2 pmol/l, pancreatic polypeptide 4 pmol/l, GIP 3 pmol/l, motilin 3 pmol/l, VIP 1.5 pmol/l, enteroglucagon 10 pmol/l, and insulin 6 pmol/l and showed no crossreaction with each other or other relevant hormones. Statistical analysis was made using Student's t test for unpaired data for parameters with normal distribution and using non-parametric (Whitney Mann U Test) methodology for parameters with a known skewed distribution.
Results
Mean fasting levels, peak postprandial rise and total integrated postprandial responses for blood glucose and for the gut hormones measured are given in the Table. Values are given as mean ± standard error of the mean.
BLOOD GLUCOSE
Patients with acute diarrhoea had significantly reduced fasting levels of blood glucose with a diminished postprandial rise, compared with control subjects. The postprandial rise was more prolonged, however, and levels were still greater than basal at 120 and 180 minutes compared with controls who had returned to basal by 120 minutes.
INSULIN
Fasting insulin concentrations were significantly greater than normal in the patients with diarrhoea (p<OO1). Postprandial insulin concentrations, however, were similar to controls. Basal concentrations of insulin in the diarrhoeal patients were 26.8±3.6 pmol/l soon after admission and 24.4±2.7 pmol/l, before discharge from hospital.
PANCREATIC POLYPEPTIDE (HPP) (Fig. 1 (Fig. 2) . Fasting plasma motilin concentrations in the healthy controls were 41±8 pmol/l (p<0.001 against recovery samples). Ingestion of the breakfast resulted in a small rise in plasma motilin (Fig. 3 ) which was greater in absolute terms in the patients with diarrhoea, but was proportionally similar in both groups.
ENTEROGLUCAGON
The patients with diarrhoea also had significantly greater fasting and postprandial plasma enteroglucagon concentrations than the healthy controls (Fig. 4) . Fasting enteroglucagon concentrations in the diarrhoeal patients shortly after admission were 78-5±91-6 pmol/l and had fallen significantly to 46.7±6-1 pmol/l (p<002) before their discharge from hospital.
VASOACTIVE INTESTINAL POLYPEPTIDE (VIP)
Fasting concentrations of VIP were significantly greater than controls in the patients with diarrhoea (p<OO1), they also had a peak postprandial rise which was higher than normal (p<O-O1 Crohn's disease.33 Further, more recent direct evidence, supporting a trophic role for enteroglucagon has come from studies using partially purified enteroglucagon in rodents. The rate of jejunal mucosal DNA synthesis was increased by approximately 50% compared with controls.35 As in patients with coeliac disease, it is possible that the degree of enteroglucagon rise, found in patients with acute diarrhoea, may relate to the nature of any changes in the mucosa of the small intestine.
A surprising finding was that of significantly lower blood glucose concentrations in the diarrhoeal patients compared with controls. One possibility is that this relative hypoglycaemia may in part result from the higher basal insulin concentrations found in these patients. After the breakfast the diarrhoeal patients had a significantly reduced peak rise in blood glucose, but in both groups, maximial concentrations were attained by 3() Iiilnutes. In controls blood glucose concentrations hatd retuirnied to basal by two hours, whereas in the dilrrhoeal patients concentrations were still sustainled ahove basal at three hours. Similar obtuniided but sustained postprandial glucose responlses were found in patients with untreated coeliat diseaise,?34 and in patients with severe tropica,l mnalabsorption. Whether pancreatic polypeptide has a similar effect in man is unknown. If this is a physiological effect, then increased concentrations of pancreatic polypeptide stimulating fluid absorption would be an appropriate compensatory response in diarrhoea. Pancreatic polypeptide has no detectable action on motor events, for example it has no influence on the migratory motor complex.37
Fasting and postprandial concentrations of VIP were significantly greater in the diarrhoeal patients than in control subjects. These concentrations were, however, of an order of magnitude less than the plasma concentrations found in the VernerMorrison or VIPoma syndrome,38 where VIP released from a pancreatic tumour passes into the circulation and causes diarrhoea by increasing net fluid loss in the small intestine. VIP is localised in neurons in the wall of the entire alimentary tract, with some of the greatest tissue concentrations in the ileum and colon.33 VIP when infused in pigs, albeit achieving supra-physiological plasma concentrations, causes diarrhoea.39 Known biological actions of VIP on the small and large intestine include inhibition of absorption, stimulation of water and ion secretion, stimulation of adenylate cyclase activity, and relaxation of colonic smooth muscle.40 Furthermore VIP has recently been described to be released from the feline small intestine when exposed to cholera toxin. It was proposed that the increased secretion might be secondary to the activation of intramural nervous reflexes in the gut.41 Thus the finding of mildly raised VIP concentrations in patients with acute diarrhoea may indicate a local role in the pathophysiological mechanisms of diarrhoea.
It is unlikely that the raised basal concentrations of many of the gut hormones measured are because of haemoconcentration. There were no significant differences from normal in the diarrhoea patients' haemoglobin, sodium, and urea concentrations. Nor were there any significant differences in the plasma concentrations of all but motilin and enteroglucagon of the peptides measured, between the initial sample taken while still suffering from diarrhoea and the final sample when symptomatically recovered.
The effect of taking nothing by mouth and total parenteral nutrition on fasting and meal stimulated gut hormone release has been studied after considerably longer time periods than the few days of intravenous therapy necessary in the diarrhoeal patients.42 There were no differences on the fasting concentrations of gastrin, motilin, GIP, secretin, pancreatic polypeptide pancreatic glucagon, enteroglucagon, or VIP during prolonged total parenteral nutrition. The peak postprandial response of enteroglucagon was higher and that of insulin was lower after the test breakfast and after prolonged total parenteral nutrition than that when repeated after normal eating. As the patients with acute diarrhoea were only on intravenous alimentation for a matter of only a few days (compared with weeks in the study above) but were allowed oral fluids as soon as these could be tolerated, it is very unlikely that any of the alterations in gut hormones found in the diarrhoea patients could be ascribed to prolonged fasting.
The importance of these preliminary findings of raised plasma concentrations of pancreatic polypeptide, motilin, enteroglucagon, and VIP in patients with diarrhoea must await further study. 
